Retension Pharmaceuticals prices upsized IPO at $12 per share (RTSN:Pending)
· seekingalpha.com
Retension Pharmaceuticals (RTSN)priced its upsized IPO at $12 per share.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...